Ferguson James J. III 4
4 · Matinas BioPharma Holdings, Inc. · Filed Dec 22, 2022
Insider Transaction Report
Form 4
Ferguson James J. III
Chief Medical Officer
Transactions
- Award
Stock Option (right to Buy)
2022-12-20+625,000→ 625,000 totalExercise: $0.53Exp: 2032-12-20→ Common Stock (625,000 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 20, 2023 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2023.